Table 3.

Atherogenic peptides recognized by T-cells from early atherosclerotic lesions (EL) and from advanced late atherosclerotic lesions (LL).

Number	Sequence	Location	Frequency
Atherogenic peptides from early atherosclerotic lesions
50	LSEKKISSIQSIVPA	246–260	2/7
54	AHRKPLVIIAEDVDG	266–280	3/7
57	EALSTLVLNRLKVGL	281–295	3/7
66	GEEGLTLNLEDVQPH	326–340	3/7
84	EKKDRVTDALNATRA	416–430	3/7
85	VTDALNATRAAVEEG	421–435	2/7
88	IVLGGGCALLRCIPA	436–450	2/7
111	KEEKDPGMGAMGGMG	551–565	5/7
Atherogenic peptides from late atherosclerotic lesions
84	EKKDRVTDALNATRA	416–430	4/8
85	VTDALNATRAAVEEG	421–435	6/8
95	TLKIPAMTIAKNAGV	471–485	6/8
96	AMTIAKNAGVEGSLI	476–490	4/8

Eight common HSP60 peptides induced a proliferative response in early atherosclerotic lesion (EL) and four in late atherosclerotic lesions (LL). Overlapping amino acids are represented in bold.